Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

02 Apr, 2019, 10:26 BST BerGenBio Extends Phase II Trial With Bemcentinib and KEYTRUDA® in NSCLC to Include Patients With Disease Progression on Immune Checkpoint Inhibitor Therapy

BerGenBio ASA (OSE: BGBIO) announces that the first patient has been dosed in an additional cohort ("Cohort B") of an ongoing Phase II open-label...


02 Apr, 2019, 10:10 BST Bempedoic Acid CLEAR Serenity Study Results Published in the JAHA Demonstrated Significant LDL-Cholesterol Lowering and Reduced hsCRP in Statin Intolerant Patients

Daiichi Sankyo Europe GMbH (hereafter, 'Daiichi Sankyo') and Esperion Therapeutics (NASDAQ: ESPR) announced today that results from the 345 patient,...


02 Apr, 2019, 06:13 BST BerGenBio: Preclinical Data Presented at AACR Reinforces Bemcentinib's Potential to Reverse Tumour Immunosuppression and Therapy Resistance

BerGenBio ASA (OSE: BGBIO) a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for multiple cancer...


02 Apr, 2019, 06:12 BST Nordic Nanovector: Promising Results From Preclinical Studies With a Novel CD37-targeted Alpha Therapy for B-cell Tumours Presented at TAT11

Nordic Nanovector ASA (OSE: NANO) notes that promising results from its preclinical research collaboration to develop a novel CD37-targeting alpha...


01 Apr, 2019, 19:29 BST Arix Bioscience plc - Autolus Presents Initial AUTO1 Data at AACR

Arix Bioscience plc (LSE: ARIX) ("Arix"), a global venture capital company focused on investing in and building breakthrough biotech companies, notes ...


01 Apr, 2019, 12:00 BST Alkermes to Present New ALKS 3831 Data From ENLIGHTEN-2 and Interim Extension Safety Study Results at 2019 Congress of the Schizophrenia International Research Society

Alkermes plc (Nasdaq: ALKS) today announced it will present new data related to its schizophrenia disease portfolio at the 2019 Congress of the...


01 Apr, 2019, 11:22 BST BerGenBio: Bemcentinib in Combination With low-dose Chemotherapy Achieves Efficacy Endpoint in AML Patients

Phase II trial evaluating bemcentinib in combination with low-dose chemotherapy in AML patients unfit for intensive therapy Bemcentinib + low-dose...


01 Apr, 2019, 09:00 BST Kazia Presents Positive Cantrixil Phase I Data at AACR Conference

Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to provide investors with a...


28 Mar, 2019, 23:29 GMT Daiichi Sankyo Confirms Plans to Accelerate BLA Submission to U.S. FDA for [Fam-] Trastuzumab Deruxtecan (DS-8201) in HER2 Positive Metastatic Breast Cancer Post T-DM1

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced plans to accelerate filing of the Biologics License Application (BLA)...


28 Mar, 2019, 13:00 GMT Barc Lab and OWL Metabolomics Announce Strategic Partnership on Deploying Metabolomic Technology in Clinical Trials

Barc Lab and OWL Metabolomics are pleased to announce they have entered into a global strategic partnership combining Barc Lab's industry leading...


28 Mar, 2019, 11:43 GMT Selvita to Separate Oncology Therapeutics and Contract Research Business Units Into Two Global Companies

Selvita (WSE: SLV), a clinical stage company engaged in the research and development of novel cancer therapies as well as provision of drug discovery ...


27 Mar, 2019, 15:33 GMT Mountain Rescue Study Launches to Investigate Use of Penthrox® (Methoxyflurane) for Trauma-related Pain in Hostile Environments

The Mundipharma network of independent associated companies announced today that the first patient has been enrolled into a new study investigating...


27 Mar, 2019, 08:44 GMT New Swiss Home Dialysis System Receives Marketing Approval: PeriSafe® Helps Thousands of Chronically Ill Kidney Patients With Peritoneal Dialysis

The Swiss medtech startup Peripal AG introduces an innovative auxiliary device for peritoneal dialysis patients. After successfully developing the...


27 Mar, 2019, 08:00 GMT Enterome to Present Data on Its Innovative Microbiome-derived Molecular Mimicry Approach to Cancer Immunotherapy at AACR 2019

Enterome SA, a clinical-stage biopharmaceutical company leveraging its unique knowledge of the key functional and molecular interactions between the...


26 Mar, 2019, 20:28 GMT Jazz Pharmaceuticals Announces Positive Top-line Results from Phase 3 Study of JZP-258 in Adult Narcolepsy Patients with Cataplexy and Excessive Daytime Sleepiness

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive top-line results from the global, double-blind, placebo-controlled,...


26 Mar, 2019, 13:00 GMT Trialbee And Linical Accelovance Group Join Forces To Integrate Patient Recruitment And Retention Services Throughout The Clinical Trial Execution Process

Trialbee, a world leading technology provider in patient matching and engagement, and Linical Accelovance Group, a market-leading, midsized, global...


26 Mar, 2019, 12:30 GMT How Leukemia Clinical Trials are Helping Practitioners Personalize Patient Care

At present, medical practitioners have few options when they are presented with a patient with leukemia. The Leukemia & Lymphoma Society's website...


26 Mar, 2019, 11:00 GMT Veeda Clinical Research Reaffirms Quality Credentials With Third Successful NPRA (Malaysian Regulatory Agency) Inspection

Veeda Clinical Research Pvt. Ltd., a leading independent CRO, is pleased to announce that our clinical (Shivalik, Ahmedabad) and Bioanalytical...


26 Mar, 2019, 07:51 GMT Diamyd Medical Announces Strategic Activities for 2019 and 2020

With experience from clinical trials in more than 1,000 patients with the diabetes vaccine Diamyd®, preparations for a Conditional Marketing...


25 Mar, 2019, 20:33 GMT Therachon Presents Data from Preclinical and Phase I clinical Studies of Apraglutide for the Treatment of Short Bowel Syndrome at ASPEN 2019 Nutrition Science & Practice Conference

Therachon AG ("Therachon"), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative...


25 Mar, 2019, 10:39 GMT Tokai University Research: Clinical Tests Show That 'Cell-sheet Accelerating Technology' Offers Promising Treatment for Osteoarthritis of the Knee

Researchers at Tokai University report in the journal npj Regenerative Medicine a regenerative medicine approach for treating osteoarthritis of the...


25 Mar, 2019, 09:00 GMT DRIVE: Call for Researchers to Join New Efforts to Study Brand-specific Influenza Vaccine Effectiveness

A call has been issued for research institutes and networks to join new efforts to increase the understanding of influenza vaccine effectiveness in...


25 Mar, 2019, 08:00 GMT New Long-Term Outcomes Data Reconfirm Value of Oncotype DX Breast Recurrence Score® Test to Target Chemotherapy

New data recently presented at the 16th St. Gallen International Breast Cancer Conference further support the utility of Oncotype DX Breast...


23 Mar, 2019, 18:00 GMT Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data presented at ENDO

Oral semaglutide 7 mg and 14 mg demonstrated superior HbA1c and body weight reductions compared to Januvia® (sitagliptin 100 mg). Non-inferiority for ...


22 Mar, 2019, 00:01 GMT BioArctic's Partner Eisai Initiates the Confirmatory Phase 3 Study of BAN2401 in Early Alzheimer's Disease

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that its partner Eisai has initiated the global Phase 3 confirmatory study of BAN2401...